Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms: A Meta-analysis
Ginecologia e ObstetríciaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Obstetrics and gynecology
- Publicado em
- 16 jan 2024
- Citações
- 12
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms: A Meta-analysis
Krishna Nikhila Bonga, Archana Mishra, Rituparna Maiti, Biswa Mohan Padhy, Bikash Ranjan Meher, Anand Srinivasan
Descritores MeSH
- Genital Diseases, Female
- Thiadiazoles
- Heterocyclic Compounds, 2-Ring
- Quality of Life
- Female
- Hot Flashes
- Humans
- Menopause
Veja também
Estudos relacionados
- Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis
- Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause
- Efficacy and safety of fezolinetant, a neurokinin-3 antagonist, in treating vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
- Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause